Startup Investment Through a CVC Fund
First written in FY2022-Q2. 2 of 4 entries say "Advanced", first in FY2022-Q3. Latest entry: FY2023.
7 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「Against this backdrop, to promote the creation of new businesses, we are advancing initiatives such as business-matching services, exploring business opportunities and strengthening collaboration with various partners.」
The direction of creating new businesses with external partners has been reaffirmed through initiatives including business-matching services and stronger partnerships. - FY2023-Q1AdvancedAnnual report
「We invested in venture companies through corporate venture capital to promote the creation of new businesses with external partners.」
The CVC fund established in the previous fiscal year had progressed to the stage of making actual investments in venture companies. - FY2022-Q3AdvancedAnnual report
「(Increase) Through the acquisition of shares: 株式会社パルテック; PALTEK Hong Kong Limited. Through the establishment of new companies: Restar-SBI Innovation Investment Limited Partnership」
The CVC fund for which the establishment agreement was signed in July 2021 was listed as a newly established consolidated subsidiary, indicating that the fund formation had reached the stage of being reflected in the scope of consolidation. - FY2022-Q2First statedAnnual report
「The Company and SBIインベストメント株式会社, a wholly owned subsidiary of SBIホールディングス株式会社, entered into an agreement dated 15 July 2021 to jointly establish the CVC (corporate venture capital) fund Restar-SBI Innovation Investment Limited Partnership, which will invest in promising domestic and overseas startups expected to generate business synergies with the Company. Fund size: ¥5 billion. Establishment date: 15 July 2021. Investment period: 10 years. Investment targets: domestic and overseas startups, primarily in DX and the medical and nursing-care fields, with potential for medium- to long-term business synergies and the creation of new businesses.」
A joint CVC fund with SBIインベストメント株式会社 was established, with a fund size of ¥5 billion and a 10-year investment period, to pursue business synergies and the creation of new businesses through investments in startups in fields including DX and medical and nursing care.